Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about JNJ

Recent news which mentions JNJ

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug
Tickers JNJ LLY NEWS
Tags Large Cap Biotech Equities
From Benzinga
Johnson & Johnson Preps For Q3 Earnings As MedTech Expands, But Stock Sends Mixed Signals
Tickers JNJ NEWS
Tags Earnings News JNJ
From Benzinga
Columbus Day: Is Stock Market Open Today?
Tickers ABT BAC JNJ NEWS
Tags Markets Stories That Matter JNJ
From Benzinga
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year
Tickers AMZN CHD CLX JNJ
Tags AMZN CHD PG
From Motley Fool
Market Whales and Their Recent Bets on JNJ Options
Tickers JNJ
Tags BZI/UOA Markets JNJ
From Benzinga
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Tickers BX GS GSK HLN
Tags Stories That Matter JNJ KVUE
From Benzinga
What Analysts Are Saying About Johnson & Johnson Stock
Tickers JNJ
Tags BZI/AAR Benzinga JNJ
From Benzinga
Insights Into Johnson &amp; Johnson's Performance Versus Peers In Pharmaceuticals Sector
Tickers JNJ NEWS
Tags JNJ BZI/IA Market News
From Benzinga
1 Vanguard Index Fund Could Turn $500 Per Month Into a $968,400 Portfolio That Pays $16,000 in Annual Dividend Income
Tickers AAPL AVGO JNJ JPM
Tags UNH XOM V
From Motley Fool
What To Expect When Johnson & Johnson Reports Q3 Earnings Next Week?
Tickers JNJ NEWS
Tags Analyst Color Expert Ideas Stories That Matter
From Benzinga
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
Tickers JNJ NEWS TAK
Tags General Health Care News
From Benzinga
2 Smart Income Stocks to Buy Right Now
Tickers JNJ KO
Tags Recent Press Releases KO JNJ
From Motley Fool
Johnson & Johnson's Options: A Look at What the Big Money is Thinking
Tickers JNJ
Tags Markets BZI/UOA JNJ
From Benzinga
Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
Tickers JNJ NEWS PFE
Tags General Briefs News
From Benzinga
Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients
Tickers JNJ LEGN NEWS
Tags Movers Briefs News
From Benzinga
2 Excellent Dividend Stocks to Buy With Less Than $200
Tickers ABT JNJ
Tags JNJ ABT Market News
From Motley Fool
Johnson & Johnson Reports Updated Data From Two Early-Stage Multiple Myeloma Studies Of Talvey Combo Treatment
Tickers JNJ NEWS
Tags Benzinga Market News JNJ
From Benzinga
In-Depth Analysis: Johnson &amp; Johnson Versus Competitors In Pharmaceuticals Industry
Tickers JNJ NEWS
Tags Market News BZI/IA JNJ
From Benzinga
Why Masimo Stock Crushed the Market Today
Tickers JNJ KFY MASI
Tags Market News MASI JNJ
From Motley Fool
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Tickers GS GSK HLN JNJ
Tags JNJ Stories That Matter KVUE
From Benzinga
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Tickers ABT JNJ
Tags Market News ABT JNJ
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers BHVN BMY BNTX CI
Tags Market News TGTX BHVN
From Benzinga
Is Johnson & Johnson Stock a Buy?
Tickers JNJ
Tags Market News JNJ Recent Press Releases
From Motley Fool
Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients
Tickers JNJ NEWS
Tags Briefs News General
From Benzinga
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
Tickers JNJ NEWS ZVRA
Tags Health Care General Biotech
From Benzinga
The Latest Analyst Ratings For Johnson & Johnson
Tickers JNJ
Tags Benzinga BZI/AAR JNJ
From Benzinga
2 Vanguard Index Funds Could Turn $400 Per Month Into $16,800 in Annual Dividend Income by Retirement
Tickers AAPL AMZN AVGO GOOG
Tags ^GSPC PG VOO
From Motley Fool
Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
Tickers AZN BGNE JNJ NEWS
Tags Health Care AZN Large Cap
From Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
Tickers BNTX JNJ MRNA NVAX
Tags MRNA SNY BNTX
From Motley Fool
Unpacking the Latest Options Trading Trends in Johnson & Johnson
Tickers JNJ
Tags Benzinga Options Markets
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.